A California jury yesterday ordered drugmaker Johnson & Johnson to pay US$417 million to a woman who claimed she developed terminal ovarian cancer after using the company’s talc-based products.
The jury made the award, which included US$347 million in punitive damages, to Eva Echeverria after she filed suit in July of last year, a representative of the Los Angeles Superior Court told AFP.
Echeverria, 63, developed the disease after decades of using Johnson & Johnson talc-based powders for feminine hygiene, according to media accounts.
In a statement Johnson & Johnson said it would lodge an appeal. “We will appeal today’s verdict because we are guided by the science which supports the safety of Johnson’s Baby Powder,” company spokesperson Carol Goodrich said in the statement.
She cited the editorial board of the National Cancer Institute’s Physician Data Query, which wrote in April that the “weight of evidence does not support” the existence of a link between ovarian cancer and exposure of the genital region to talc.
So far juries in St Louis, Missouri, have also awarded damages against Johnson & Johnson totalling more than US$307 million in similar talc cases.
Source: Jamaica Observer
